Color visual evoked potentials in children with type 1 diabetes: relationship to metabolic control

Yesmino T Elia1, Denis Daneman, Joanne Rovet

  • 1Department of Ophthalmology and Vision Sciences, The Hospital for Sick Children and University of Toronto, Canada.

Insights

Pubertal status, not blood sugar control (HbA1c), impacts blue-yellow color vision in children with type 1 diabetes (T1D). Puberty delays short-wavelength visual evoked potential (VEP) responses in these children.

Area of Science:

  • Ophthalmology
  • Pediatric Endocrinology
  • Neuroscience

Background:

  • Type 1 diabetes (T1D) can affect visual pathways.
  • Metabolic control, indicated by HbA1c, is crucial for managing T1D complications.
  • Chromatic visual mechanisms may be sensitive indicators of early neuro-visual changes in T1D.

Purpose of the Study:

  • To investigate the relationship between glycemic control (HbA1c) and color vision using visual evoked potentials (VEPs) in children with T1D.
  • To assess if metabolic control affects short-wavelength (S-VEP) and long-medium-wavelength (LM-VEP) visual pathways.

Main Methods:

  • Fifty children with T1D and 33 controls (ages 6-12.9) underwent VEP testing.
  • Color stimuli (S-VEP, LM-VEP) and achromatic stimuli were presented.
  • VEP latency was analyzed in relation to HbA1c and pubertal status using ANCOVA regression.

Main Results:

  • No significant association was found between HbA1c levels and S-VEP, LM-VEP, or achromatic VEP latency.
  • Pubertal status significantly impacted S-VEP latency (P=0.0114).
  • Pubertal children with T1D exhibited delayed S-VEP latency (mean 9.5 ms) compared to prepubertal children, with no significant difference between T1D and control groups regarding this effect.

Conclusions:

  • Pubertal status, rather than HbA1c, selectively influences S-VEP latency in preteen children with T1D.
  • Further research is needed to track S-VEP latency changes over time in pubertal T1D children.
  • Delayed S-VEP latency may serve as a potential predictive marker for diabetic retinopathy development.
Abstract

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...